Pathology Doctors in Petersburg, VA Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Dr. Danna Elizabeth Johnson, MD Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Blvd, Petersburg, VA 23805 Phone: 615-221-4400

Dr. Manuel Borja Gonzales, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 801 S Adams St, Laboratory, Petersburg, VA 23803 Phone: 804-862-5010

Dr. Edward Peter Nikicicz, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 801 S Adams St, Srmc, Lab, Petersburg, VA 23803 Phone: 804-862-5028

Brad Thomas Siegmund, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Park Blvd, Petersburg, VA 23805 Phone: 804-862-5010

Dr. John William Summerville, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Blvd, Petersburg, VA 23805 Phone: 615-221-4400

News Archive

What are the anti-COVID drugs currently in development?

The first antiviral drugs effective against COVID-19 were recently approved in the UK and USA. A researcher from the Laboratory of Gene Technology has been exploring what we know so far.

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Linneah sat at a desk at the Center for Sexual Medicine at Sheppard Pratt in the suburbs of Baltimore and filled out a questionnaire. She read briskly, making swift checks beside her selected answers, and when she was finished, she handed the pages across the desk to Martina Miller, who gave her a round of pills.

Medical science continues to neglect female talent

Women are under-represented in academic medicine resulting in a waste of public investment due to loss of research talent. Writing in the July issue of the Journal of the Royal Society of Medicine, authors of an essay on women and academic medicine say that as a consequence of female under-representation, some areas of medicine are under-researched at a cost to patients and society.

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

Study reveals potential therapeutic target for treating cocaine addiction

A new study explains how cocaine modifies functions in the brain revealing a potential target for therapies aimed at treating cocaine addiction.

Read more Medical News

› Verified 3 days ago